These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. Barber A; Robson SC; Myatt L; Bulmer JN; Lyall F FASEB J; 2001 May; 15(7):1158-68. PubMed ID: 11344084 [TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction. Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587 [TBL] [Abstract][Full Text] [Related]
5. [Catalase activity in normal and preeclamptic placentas]. Wiktor H; Kankofer M Ginekol Pol; 2001 Dec; 72(12):1228-32. PubMed ID: 11883241 [TBL] [Abstract][Full Text] [Related]
6. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. Nevo O; Many A; Xu J; Kingdom J; Piccoli E; Zamudio S; Post M; Bocking A; Todros T; Caniggia I J Clin Endocrinol Metab; 2008 Jan; 93(1):285-92. PubMed ID: 17956955 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies. Rutherford RA; McCarthy A; Sullivan MH; Elder MG; Polak JM; Wharton J Br J Pharmacol; 1995 Dec; 116(8):3099-109. PubMed ID: 8719783 [TBL] [Abstract][Full Text] [Related]
8. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914 [TBL] [Abstract][Full Text] [Related]
9. Inflammasome activation in preeclampsia and intrauterine growth restriction. Silber M; Dekel N; Heusler I; Biron-Shental T; Amiel A; Kidron D; Weisz A; Benchetrit S; Zitman-Gal T Am J Reprod Immunol; 2022 Oct; 88(4):e13598. PubMed ID: 35976163 [TBL] [Abstract][Full Text] [Related]
10. Apparent systemic 11ß-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction. Vasku M; Kleine-Eggebrecht N; Rath W; Mohaupt MG; Escher G; Pecks U Pregnancy Hypertens; 2018 Jan; 11():7-11. PubMed ID: 29523277 [TBL] [Abstract][Full Text] [Related]
11. An image analysis technique for the investigation of variations in placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction. Daayana S; Baker P; Crocker I J Soc Gynecol Investig; 2004 Dec; 11(8):545-52. PubMed ID: 15582500 [TBL] [Abstract][Full Text] [Related]
12. Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology. Awamleh Z; Gloor GB; Han VKM BMC Med Genomics; 2019 Jun; 12(1):91. PubMed ID: 31248403 [TBL] [Abstract][Full Text] [Related]
13. Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia. Huang X; Anderle P; Hostettler L; Baumann MU; Surbek DV; Ontsouka EC; Albrecht C BMC Genomics; 2018 Mar; 19(1):173. PubMed ID: 29499643 [TBL] [Abstract][Full Text] [Related]
14. Differential Receptor for Advanced Glycation End Products Expression in Preeclamptic, Intrauterine Growth Restricted, and Gestational Diabetic Placentas. Alexander KL; Mejia CA; Jordan C; Nelson MB; Howell BM; Jones CM; Reynolds PR; Arroyo JA Am J Reprod Immunol; 2016 Feb; 75(2):172-80. PubMed ID: 26682535 [TBL] [Abstract][Full Text] [Related]
15. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women. Laskowska M; Laskowska K; Oleszczuk J J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708 [TBL] [Abstract][Full Text] [Related]
16. Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR. Aiko Y; Askew DJ; Aramaki S; Myoga M; Tomonaga C; Hachisuga T; Suga R; Kawamoto T; Tsuji M; Shibata E BMC Pregnancy Childbirth; 2014 May; 14():181. PubMed ID: 24886642 [TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism in the human preterm and term placenta of IUGR fetuses. Magnusson AL; Powell T; Wennergren M; Jansson T Placenta; 2004 Apr; 25(4):337-46. PubMed ID: 15028426 [TBL] [Abstract][Full Text] [Related]
18. Placental apoptosis in preeclampsia, intrauterine growth retardation, and HELLP syndrome: an immunohistochemical study with caspase-3 and bcl-2. Cali U; Cavkaytar S; Sirvan L; Danisman N Clin Exp Obstet Gynecol; 2013; 40(1):45-8. PubMed ID: 23724505 [TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of SATB1 and wnt/β-catenin signaling molecule in the placenta of preeclampsia]. Zhuang B; Luo X; Rao H; Li Q; Liu X; Qi H Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):283-90. PubMed ID: 26080941 [TBL] [Abstract][Full Text] [Related]
20. [Glutathione peroxidase activity in normal and preeclamptic placentas]. Wiktor H; Kankofer M; Zrubek H; Kotarski J Ginekol Pol; 2000 Aug; 71(8):799-803. PubMed ID: 11082925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]